Literature DB >> 22316157

Multi-parameter optimization: identifying high quality compounds with a balance of properties.

Matthew D Segall1.   

Abstract

A successful, efficacious and safe drug must have a balance of properties, including potency against its intended target, appropriate absorption, distribution, metabolism, and elimination (ADME) properties and an acceptable safety profile. Achieving this balance of, often conflicting, requirements is a major challenge in drug discovery. Approaches to simultaneously optimizing many factors in a design are broadly described under the term 'multi-parameter optimization' (MPO). In this review, we will describe how MPO can be applied to efficiently design and select high quality compounds and describe the range of methods that have been employed in drug discovery, including; simple 'rules of thumb' such as Lipinski's rule; desirability functions; Pareto optimization; and probabilistic approaches that take into consideration the uncertainty in all drug discovery data due to predictive error and experimental variability. We will explore how these methods have been applied to predicted and experimental data to reduce attrition and improve the productivity of the drug discovery process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22316157     DOI: 10.2174/138161212799436430

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  24 in total

1.  Can we really do computer-aided drug design?

Authors:  Matthew Segall
Journal:  J Comput Aided Mol Des       Date:  2011-12-11       Impact factor: 3.686

2.  Exploring Modifications of an HIV-1 Capsid Inhibitor: Design, Synthesis, and Mechanism of Action.

Authors:  Jimmy P Xu; Ashwanth C Francis; Megan E Meuser; Marie Mankowski; Roger G Ptak; Adel A Rashad; Gregory B Melikyan; Simon Cocklin
Journal:  J Drug Des Res       Date:  2018-08-13

Review 3.  QSAR without borders.

Authors:  Eugene N Muratov; Jürgen Bajorath; Robert P Sheridan; Igor V Tetko; Dmitry Filimonov; Vladimir Poroikov; Tudor I Oprea; Igor I Baskin; Alexandre Varnek; Adrian Roitberg; Olexandr Isayev; Stefano Curtarolo; Denis Fourches; Yoram Cohen; Alan Aspuru-Guzik; David A Winkler; Dimitris Agrafiotis; Artem Cherkasov; Alexander Tropsha
Journal:  Chem Soc Rev       Date:  2020-05-01       Impact factor: 54.564

4.  ALOHA: a novel probability fusion approach for scoring multi-parameter drug-likeness during the lead optimization stage of drug discovery.

Authors:  Derek A Debe; Ravindra B Mamidipaka; Robert J Gregg; James T Metz; Rishi R Gupta; Steven W Muchmore
Journal:  J Comput Aided Mol Des       Date:  2013-10-11       Impact factor: 3.686

Review 5.  Chemical predictive modelling to improve compound quality.

Authors:  John G Cumming; Andrew M Davis; Sorel Muresan; Markus Haeberlein; Hongming Chen
Journal:  Nat Rev Drug Discov       Date:  2013-12       Impact factor: 84.694

6.  The challenges of making decisions using uncertain data.

Authors:  Matthew D Segall; Edmund J Champness
Journal:  J Comput Aided Mol Des       Date:  2015-07-01       Impact factor: 3.686

7.  A desirability function-based scoring scheme for selecting fragment-like class A aminergic GPCR ligands.

Authors:  Ádám A Kelemen; György G Ferenczy; György M Keserű
Journal:  J Comput Aided Mol Des       Date:  2014-10-19       Impact factor: 3.686

Review 8.  Advances in Drug Discovery and Development in Geriatric Psychiatry.

Authors:  Alexander C Conley; Paul A Newhouse
Journal:  Curr Psychiatry Rep       Date:  2018-03-05       Impact factor: 5.285

9.  VPR-254: an inhibitor of ROR-gamma T with potential utility for the treatment of inflammatory bowel disease.

Authors:  Leo R Fitzpatrick; Jeff Small; Robert O'Connell; George Talbott; Gordon Alton; Jim Zapf
Journal:  Inflammopharmacology       Date:  2019-09-23       Impact factor: 4.473

10.  Therapeutic potential of small molecules and engineered proteins.

Authors:  Eugenia V Gurevich; Vsevolod V Gurevich
Journal:  Handb Exp Pharmacol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.